BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
Biotech catalysts in 2026-05
177 industry Phase 2/3 trial readout(s) and 39 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.
FDA decision events
Trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-05 est. | P1/P2 | AbbVie ABBV | NCT03933735 A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma | Multiple Myeloma | active not recruiting | 220 |
| 2026-05 est. | P3 | GC Biopharma Corp | NCT04565015 Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency | Primary Immune Deficiency | active not recruiting | 24 |
| 2026-05 est. | P3 | EMS | NCT04594018 Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia | Androgenetic Alopecia | recruiting | 190 |
| 2026-05 est. | P3 | EMS | NCT04602754 Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. | Dyslipidemia Associated With Type II Diabetes Mellitus | recruiting | 228 |
| 2026-05 est. | P3 | EMS | NCT05052879 Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation | Erectile Dysfunction; Premature Ejaculation | unknown | 232 |
| 2026-05 est. | P3 | Akeso | NCT05235516 A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer | Locally Advanced Cervical Carcinoma | active not recruiting | 636 |
| 2026-05 est. | P1/P2 | Jiangsu HengRui Medicine Co., Ltd. | NCT05277168 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS | Advanced Solid Tumors | recruiting | 83 |
| 2026-05 est. | P3 | PT Bio Farma | NCT05482295 Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III) | Vaccine Reaction; Vaccine Adverse Reaction | not yet recruiting | 540 |
| 2026-05 est. | P3 | UnicoCell Biomed CO. LTD | NCT05526001 Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis | Knee Osteoarthritis | active not recruiting | 165 |
| 2026-05 est. | P2 | Beijing InnoCare Pharma Tech Co., Ltd. | NCT05678270 A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma (ICC) | recruiting | 70 |
| 2026-05 est. | P1/P2 | SURGE Therapeutics SRGXF | NCT05710848 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer | Non-muscle-invasive Bladder Cancer | recruiting | 75 |
| 2026-05 est. | P1/P2 | Iterion Therapeutics | NCT05797805 A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | recruiting | 178 |
| 2026-05 est. | P3 | EMS | NCT05886088 Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus | Type 2 Diabetes Mellitus | not yet recruiting | 597 |
| 2026-05 est. | P3 | Jiangsu HengRui Medicine Co., Ltd. | NCT06122389 SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma | Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy | recruiting | 130 |
| 2026-05 est. | P1/P2 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | NCT06241235 Study of ZG005 in Combination With Paclitaxel+Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma | Cervical Carcinoma | unknown | 48 |
| 2026-05 est. | P2 | GCP-Service International West GmbH | NCT06243458 RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms | Low Risk Myelodysplastic Syndromes | active not recruiting | 41 |
| 2026-05 est. | P2 | Noorik Biopharmaceuticals AG | NCT06256432 Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome | Hepatorenal Syndrome; Liver Cirrhosis; Acute Kidney Injury; Ascites Hepatic | active not recruiting | 54 |
| 2026-05 est. | P1/P2 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | NCT06440057 Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participant | Neuroendocrine Carcinoma | recruiting | 78 |
| 2026-05 est. | P2 | NanoEcho AB | NCT06693375 To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Pati | Healthy Volunteers; Rectal Cancer Patients | recruiting | 12 |
| 2026-05 est. | P2 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | NCT06798207 A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced | Gynecological Tumors | recruiting | 170 |
| 2026-05 est. | P1/P2 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | NCT06829771 Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma | Diffuse Large B Cell Lymphoma | recruiting | 90 |
| 2026-05 est. | P3 | Beijing InnoCare Pharma Tech Co., Ltd. | NCT06842199 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis | Plaque Psoriasis Patients | recruiting | 383 |
| 2026-05 est. | P3 | Keymed Biosciences Co.Ltd | NCT06956196 Study of Stapokibatrt in Children Subjects With Atopic Dermatitis | Atopic Dermatitis | not yet recruiting | 240 |
| 2026-05 est. | P1/P2 | GC Biopharma Corp | NCT06997627 A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults | Tetanus-diphtheria-acellular Pertussis (Tdap) | recruiting | 120 |
| 2026-05 est. | P2 | RDC Clinical Pty Ltd | NCT07028528 Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy | recruiting | 80 |
| 2026-05 est. | P1/P2 | Sirius Therapeutics Co., Ltd. SIRI | NCT07172646 A Study of SRSD216 in Patients With Elevated Lipoprotein (a) | Hyperlipoproteinemia (a) | recruiting | 84 |
| 2026-05 est. | P2 | GI Innovation, Inc. | NCT07363057 A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors | Cancer Survivors; Healthy Participant; Elderly | recruiting | 15 |
| 2026-05-01 est. | P1/P2 | GlaxoSmithKline | NCT04006808 A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant | Herpes Zoster | recruiting | 184 |
| 2026-05-01 | P3 | Eli Lilly and Company LLY | NCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis | Ulcerative Colitis | completed | 63 |
| 2026-05-01 est. | P1/P2 | Akeso | NCT05951608 A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | active not recruiting | 216 |
| 2026-05-01 est. | P3 | Beijing Dongfang Biotech Co., Ltd. | NCT06254014 A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients | Type 2 Diabetes Mellitus | active not recruiting | 270 |
| 2026-05-01 est. | P1/P2 | Chengdu Zenitar Biomedical Technology Co., Ltd | NCT06431243 A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors | Advanced Solid Tumor | recruiting | 132 |
| 2026-05-01 | P2 | Shanghai HEP Pharmaceutical Co., Ltd. | NCT06505928 A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D | Hepatitis D | completed | 90 |
| 2026-05-01 | P2 | Eli Lilly and Company LLY | NCT06538116 A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease | Alzheimer Disease | completed | 304 |
| 2026-05-01 est. | P2 | Bavarian Nordic | NCT06549530 Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Preve | Monkeypox (Mpox) | active not recruiting | 460 |
| 2026-05-01 est. | P2 | Akeso | NCT06560112 An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer | Recurrent Ovarian Cancer | recruiting | 172 |
| 2026-05-01 | P2 | BioVie Inc. BIVI | NCT06757010 A Study of NE3107 in Early Parkinson's | Parkinsons Disease (PD) | completed | 57 |
| 2026-05-01 est. | P2 | PharmaJet, Inc. | NCT06919796 mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes | Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery | not yet recruiting | 40 |
| 2026-05-01 | P3 | BioNTech SE BNTX | NCT07069309 A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher | COVID-19; SARS-COV-2 Infection | completed | 774 |
| 2026-05-01 | P3 | Sanofi SNY | NCT07135986 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China | Meningococcal Infection; Healthy Volunteers | completed | 1602 |
| 2026-05-01 est. | P3 | Chengdu CoenBiotech Co., Ltd | NCT07152639 Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above | Tuberculosis | recruiting | 1784 |
| 2026-05-02 | P3 | Regeneron Pharmaceuticals REGN | NCT07309432 Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy | Allergic Conjunctivitis | terminated | 24 |
| 2026-05-04 | P2 | Hoffmann-La Roche | NCT05808764 A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy | Muscular Atrophy, Spinal | completed | 11 |
| 2026-05-04 | P3 | Neumora Therapeutics, Inc. NMRA | NCT06058039 Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder | Major Depressive Disorder | completed | 422 |
| 2026-05-04 | P1/P2 | Neuracle Science Co., LTD. | NCT06249919 A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients | Seneorineural Deafness; Sudden Sensorineural Hearing Loss | completed | 113 |
| 2026-05-04 | P2 | AstraZeneca AZN | NCT06606847 A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung | Non-Small Cell Lung Cancer | active not recruiting | 30 |
| 2026-05-05 est. | P2 | Rocket Pharmaceuticals Inc. RCKT | NCT04248439 Gene Therapy for Fanconi Anemia, Complementation Group A | Fanconi Anemia Complementation Group A | active not recruiting | 5 |
| 2026-05-05 | P3 | KAZM Pharmaceuticals Inc. | NCT06202989 Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty | Postsurgical Pain | completed | 306 |
| 2026-05-05 | P2 | Knoa Pharma LLC | NCT06545916 Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder | Alcohol Use Disorder | completed | 209 |
| 2026-05-06 | P1/P2 | Nerviano Medical Sciences | NCT04910022 Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma | Glioblastoma; Diffuse Glioma | terminated | 80 |
| 2026-05-06 | P3 | Neumora Therapeutics, Inc. NMRA | NCT06058013 Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder | Major Depressive Disorder | completed | 430 |
| 2026-05-06 | P3 | Gilead Sciences GILD | NCT06060665 Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) | Primary Biliary Cholangitis | completed | 96 |
| 2026-05-06 | P2 | Regeneron Pharmaceuticals REGN | NCT06593600 Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) | Postural Orthostatic Tachycardia Syndrome (POTS) | completed | 82 |
| 2026-05-06 | P2 | Celldex Therapeutics CLDX | NCT06727552 A Study of Barzolvolimab in Patients With Atopic Dermatitis | Atopic Dermatitis | active not recruiting | 131 |
| 2026-05-06 est. | P2 | Longbio Pharma | NCT07212426 Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients. | PNH - Paroxysmal Nocturnal Hemoglobinuria | active not recruiting | 30 |
| 2026-05-07 | P3 | Servier | NCT06780930 Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation | Residual or Recurrent Grade 2 IDH Mutant Glioma | active not recruiting | 57 |
| 2026-05-07 | P3 | Aardvark Therapeutics, Inc. AARD | NCT06828861 ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial | Hyperphagia; Prader-Willi Syndrome | terminated | 68 |
| 2026-05-07 | P2 | CinDome Pharma, Inc. | NCT06899217 A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis. | Idiopathic Gastroparesis | completed | 416 |
| 2026-05-07 | P3 | Laboratorios Silanes S.A. de C.V. | NCT07901894 Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea | Primary Dysmenorrhea | completed | 130 |
| 2026-05-08 | P2 | Oneness Biotech Co., Ltd. | NCT05018299 Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma | Severe Asthma | completed | 21 |
| 2026-05-08 est. | P1/P2 | Akeso | NCT05846867 A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer | Colorectal Cancer | active not recruiting | 170 |
| 2026-05-08 | P2/P3 | Oneness Biotech Co., Ltd. | NCT06531512 Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers | Diabetic Foot Ulcer | active not recruiting | 120 |
| 2026-05-08 | P2 | Otsuka Pharmaceutical Development & Commercialization, Inc. | NCT06637514 A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria | Phenylketonuria (PKU) | completed | 14 |
| 2026-05-09 | P1/P2 | Akeso | NCT05235542 A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | Advanced Malignant Tumors | completed | 128 |
| 2026-05-10 est. | P1/P2 | Cell Energy Life Sciences Group Co. LTD | NCT06416709 Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases | Lung Injury | unknown | 80 |
| 2026-05-11 | P2 | Incyte Corporation INCY | NCT04640025 A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib | Myelofibrosis; Postlung Transplant (Bronchiolitis Obliterans); Chronic Graft Versus Host Disease | terminated | 18 |
| 2026-05-11 | P1/P2 | InxMed (Shanghai) Co., Ltd. | NCT05551507 IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | active not recruiting | 150 |
| 2026-05-11 | P2 | NMD Pharma A/S | NCT05794139 Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy | Spinal Muscular Atrophy | completed | 52 |
| 2026-05-11 | P3 | Novartis Pharmaceuticals NVS | NCT05976243 A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamine | Chronic Inducible Urticaria | active not recruiting | 362 |
| 2026-05-11 | P2 | Ono Pharmaceutical Co., Ltd. | NCT06708416 A Study of ONO-1110 in Patients With Postherpetic Neuralgia | Postherpetic Neuralgia | completed | 142 |
| 2026-05-11 | P2 | AstraZeneca AZN | NCT06862791 A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone | Obesity or Overweight | completed | 377 |
| 2026-05-11 | P2 | GlaxoSmithKline | NCT07121192 A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older | Influenza, Human | completed | 776 |
| 2026-05-12 | P1/P2 | Novartis Pharmaceuticals NVS | NCT03374657 A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa | Retinitis Pigmentosa | completed | 12 |
| 2026-05-12 | P1/P2 | ModernaTX, Inc. | NCT05575492 A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age | Cytomegalovirus | completed | 873 |
| 2026-05-12 | P1/P2 | Pfizer PFE | NCT06182124 A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults | Pneumococcal Disease | completed | 1710 |
| 2026-05-12 est. | P3 | Sinovac Life Sciences Co., Ltd. | NCT06617715 Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine | Pneumococcal Infectious Disease | recruiting | 3080 |
| 2026-05-12 | P2 | Shanghai Juncell Therapeutics | NCT06703398 A Study of GC101 TIL in Advanced Melanoma | Melanoma | recruiting | 98 |
| 2026-05-12 | P2 | Agios Pharmaceuticals, Inc. AGIO | NCT06924970 A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) | Sickle Cell Disease | active not recruiting | 59 |
| 2026-05-12 | P2 | BeiGene | NCT07100938 A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis | Rheumatoid Arthritis | terminated | 49 |
| 2026-05-12 | P3 | Biocad | NCT07119372 Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis | Anemia; Chronic Kidney Disease; Chronic Kidney Disease Patients on Hemodialysis; Chronic Kidney Dise | active not recruiting | 228 |
| 2026-05-13 | P2 | Virogen Biotechnology Inc. | NCT02943642 Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | Mycosis Fungoides | withdrawn | |
| 2026-05-13 est. | P3 | CeleCor Therapeutics | NCT04825743 A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI | ST-elevation Myocardial Infarction (STEMI) | active not recruiting | 2463 |
| 2026-05-13 | P3 | Otsuka Pharmaceutical Development & Commercialization, Inc. | NCT05248646 Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) | Immunoglobulin A Nephropathy | active not recruiting | 530 |
| 2026-05-13 | P2 | Sanofi SNY | NCT05731128 A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulce | Colitis Ulcerative | active not recruiting | 68 |
| 2026-05-13 | P3 | AstraZeneca AZN | NCT06194825 EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Card | Transthyretin Amyloid Cardiomyopathy | active not recruiting | 64 |
| 2026-05-13 | P3 | AstraZeneca AZN | NCT06465485 STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma | Severe Eosinophilic Asthma | completed | 504 |
| 2026-05-13 | P3 | Eli Lilly and Company LLY | NCT06921759 A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis | Atopic Hand and Foot Dermatitis | completed | 221 |
| 2026-05-14 | P2 | Hoffmann-La Roche | NCT05686551 GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest H | Huntington Disease | active not recruiting | 301 |
| 2026-05-14 | P2 | GlaxoSmithKline | NCT06079190 Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease | Alzheimer's Disease | terminated | 367 |
| 2026-05-14 | P2 | Amgen AMGN | NCT06376045 A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma | Asthma | terminated | 317 |
| 2026-05-14 | P1/P2 | Janssen Research & Development, LLC | NCT06532032 A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer | Carcinoma, Non-Small-Cell Lung | completed | 12 |
| 2026-05-14 | P2/P3 | Praxis Precision Medicines PRAX | NCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) | Focal Seizure | completed | 255 |
| 2026-05-14 est. | P2 | R-Pharm International, LLC | NCT07553988 A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | active not recruiting | 120 |
| 2026-05-15 | P3 | AstraZeneca AZN | NCT03847428 Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment | Hepatocellular Carcinoma | completed | 908 |
| 2026-05-15 est. | P2 | Akeso | NCT05382442 A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer | Metastatic Colorectal Cancer | active not recruiting | 254 |
| 2026-05-15 | P1/P2 | Inflammasome Therapeutics | NCT06164587 Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy | Geographic Atrophy; Age-Related Macular Degeneration | completed | 30 |
| 2026-05-15 | P3 | Intra-Cellular Therapies, Inc. | NCT06462612 Study of Lumateperone in the Treatment of Patients With Bipolar Mania | Bipolar Disorder, Manic | completed | 351 |
| 2026-05-15 est. | P2 | Estar Medical dba Medical Technologies, LTD | NCT06810726 Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound | Diabetic Foot Ulcer; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus (T2DM); Neuroischemic Foot U | recruiting | 30 |
| 2026-05-15 | P3 | Samson Clinical Operations Pty Ltd | NCT06924632 Efficacy & Safety of Minoxidil SL Tablets in Men With AGA | Androgenetic Alopecia; Male Pattern Baldness | completed | 142 |
| 2026-05-15 | P2 | Genmab GMAB | NCT06984328 Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With | Cutaneous Melanoma; Relapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, o | terminated | 1 |
| 2026-05-15 | P2 | Jiangsu HengRui Medicine Co., Ltd. | NCT07404579 Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults | Neuromuscular Blockade | completed | 103 |
| 2026-05-17 | P3 | Shandong Boan Biotechnology Co., Ltd | NCT06022861 A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Car | Esophageal Squamous Cell Carcinoma | active not recruiting | 510 |
| 2026-05-18 | P1/P2 | Merck Sharp & Dohme LLC MRK | NCT04305054 Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanc | Melanoma | completed | 335 |
| 2026-05-18 | P1/P2 | Xilio Development, Inc. XLO | NCT04896697 Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors | Advanced Solid Tumor | completed | 125 |
| 2026-05-18 | P2 | Osivax | NCT05569239 Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg | Influenza | completed | 2891 |
| 2026-05-18 | P3 | Seagen, a wholly owned subsidiary of Pfizer | NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer | Carcinoma, Non-Small-Cell Lung | active not recruiting | 762 |
| 2026-05-18 | P2 | Shionogi Inc. | NCT06017609 Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction | Chronic Heart Failure | completed | 314 |
| 2026-05-18 | P2 | Bausch & Lomb Incorporated BLCO | NCT07168902 Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension | Glaucoma | completed | 252 |
| 2026-05-19 | P3 | Hoffmann-La Roche | NCT06497556 A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Met | Non-Small Cell Lung Cancer; KRAS G12C Lung Cancer | active not recruiting | 338 |
| 2026-05-19 | P1/P2 | Genentech, Inc. | NCT06850922 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in | Diabetic Macular Edema | completed | 388 |
| 2026-05-20 | P2 | Kowa Research Institute, Inc. | NCT05327127 Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis | NASH | completed | 228 |
| 2026-05-20 | P3 | Definium Therapeutics US, Inc. DFTX | NCT06941844 A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) | Major Depressive Disorder | active not recruiting | 149 |
| 2026-05-20 | P2 | Instituto Grifols, S.A. | NCT07264517 Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED). | Dry Eye Disease | completed | 103 |
| 2026-05-22 | P3 | Sanofi SNY | NCT05280548 A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease | Fabry Disease | active not recruiting | 104 |
| 2026-05-22 | P3 | Karyopharm Therapeutics Inc KPTIQ | NCT05611931 Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma | Endometrial Cancer | active not recruiting | 257 |
| 2026-05-22 | P1/P2 | Otsuka Beijing Research Institute | NCT06091267 PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes | Myelodysplastic Syndromes | active not recruiting | 72 |
| 2026-05-22 | P3 | Hoffmann-La Roche | NCT06176352 A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia | Choroidal Neovascularization Secondary to Pathologic Myopia | completed | 280 |
| 2026-05-22 | P3 | Soligenix SNGX | NCT06470451 Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL | CTCL/ Mycosis Fungoides; CTCL; Mycosis Fungoides; Cutaneous T Cell Lymphoma | terminated | 70 |
| 2026-05-22 | P1/P2 | Sanofi Pasteur, a Sanofi Company SNY | NCT06744205 A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older | Influenza; Healthy Volunteers | completed | 1162 |
| 2026-05-23 | P3 | BeOne Medicines ONC | NCT04164199 Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies | Advanced Malignancies | completed | 404 |
| 2026-05-23 | P2 | Hutchmed HCM | NCT06601504 Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | completed | 61 |
| 2026-05-25 | P3 | Polaris Group PII | NCT05712694 Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) | Soft Tissue Sarcoma | terminated | 218 |
| 2026-05-25 | P2 | ModernaTX, Inc. | NCT06143046 A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers | Respiratory Syncytial Virus | completed | 360 |
| 2026-05-25 | P1/P2 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFM | NCT06324812 Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis | Dermatitis, Atopic | completed | 128 |
| 2026-05-25 | P2 | Ono Pharmaceutical Co., Ltd. | NCT06805565 A Study of ONO-1110 in Patients With Social Anxiety Disorder | Social Anxiety Disorder (SAD) | completed | 115 |
| 2026-05-25 | P3 | Janssen Research & Development, LLC | NCT06878404 A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis | Arthritis, Psoriatic | active not recruiting | 552 |
| 2026-05-25 est. | P3 | Changchun BCHT Biotechnology Co. | NCT07500207 A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) | Rabies Prevention | enrolling by invitation | 3000 |
| 2026-05-26 | P3 | UCB Biopharma SRL | NCT04009499 A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis | Psoriatic Arthritis | completed | 1131 |
| 2026-05-26 | P1/P2 | Nacuity Pharmaceuticals, Inc. | NCT05994534 PK and PD Study of NPI-001 and Cysteamine Bitartrate | Cystinosis | completed | 8 |
| 2026-05-26 | P3 | Seqirus | NCT06087640 A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults | Influenza, Human | completed | 38769 |
| 2026-05-26 | P2 | Syqe Medical | NCT06490445 A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) | Diabetic Peripheral Neuropathic Pain | completed | 122 |
| 2026-05-26 est. | P2 | JenKem Technology Co., Ltd. | NCT06586866 JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases | Triple Negative Breast Cancer (TNBC); Brain Metastasases | unknown | 25 |
| 2026-05-26 | P2 | Pulmovant, Inc. | NCT06635850 A Study of Mosliciguat in PH-ILD | Pulmonary Hypertension; Interstitial Lung Disease; Lung Diseases; Vascular Diseases; Cardiovascular | active not recruiting | 135 |
| 2026-05-26 | P2 | AstraZeneca AZN | NCT06851858 Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor A | Endocrinology; Diabetes, Type II; Obesity | completed | 69 |
| 2026-05-26 est. | P2 | Shanghai Mabgeek Biotech.Co.Ltd | NCT07054034 Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects | Bronchial Asthma | active not recruiting | 160 |
| 2026-05-26 est. | P2 | Circul'Egg | NCT07493850 Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals | Facial Wrinkles; Skin Hydration; Skin Elasticity | active not recruiting | 60 |
| 2026-05-27 | P3 | Bristol-Myers Squibb BMY | NCT03383458 A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation | Hepatocellular Carcinoma; Liver Cancer | active not recruiting | 545 |
| 2026-05-27 | P1/P2 | Genenta Science SAEN | NCT03866109 A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT | Glioblastoma Multiforme | terminated | 25 |
| 2026-05-27 | P3 | KalVista Pharmaceuticals, Ltd. | NCT05505916 An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Pa | Hereditary Angioedema | completed | 145 |
| 2026-05-27 | P3 | KalVista Pharmaceuticals, Ltd. | NCT05511922 PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial | Hereditary Angioedema | completed | 11 |
| 2026-05-27 | P2 | Microbiome Health Sciences | NCT05556824 Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD | Gastroesophageal Reflux | completed | 255 |
| 2026-05-27 | P1/P2 | Elisigen, Inc. | NCT05984927 NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration | Age-Related Macular Degeneration | active not recruiting | 20 |
| 2026-05-27 | P2 | ViiV Healthcare | NCT05996471 A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Hu | HIV Infections | active not recruiting | 185 |
| 2026-05-27 | P3 | Epion Therapeutics | NCT06100939 Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus | Keratoconus | completed | 396 |
| 2026-05-27 | P1/P2 | Lakefront Biotherapeutics NV LKFT | NCT06561425 A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma; Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell | terminated | 130 |
| 2026-05-27 | P2/P3 | Jiangsu HengRui Medicine Co., Ltd. | NCT07036419 A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients | Operative Sedation of Pediatric; Operative Sedation of Adolescent Patients | completed | 249 |
| 2026-05-27 | P2 | NodThera Ltd. (a Rezera company) | NCT07055516 Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus | Obesity and Type 2 Diabetes | completed | 176 |
| 2026-05-27 | P1/P2 | Rubedo Life Sciences, Inc. | NCT07340697 Evaluate RLS-1496 Topical Cream for Actinic Keratosis | Actinic Keratosis (AK) | active not recruiting | 24 |
| 2026-05-27 | P2 | Sam Chun Dang Pharm. Co. Ltd. | NCT07501052 Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic | Neovascular (Wet) Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular Edema; | completed | 33 |
| 2026-05-27 | P2 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | NCT07716618 A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD) | Chronic Kidney Disease | active not recruiting | 320 |
| 2026-05-28 | P3 | Ipsen | NCT06047444 A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults | Chronic Migraine | active not recruiting | 759 |
| 2026-05-28 | P2 | Gilead Sciences GILD | NCT06513312 Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) | Pre-Exposure Prophylaxis of HIV Infection | active not recruiting | 268 |
| 2026-05-28 | P3 | MoonLake Immunotherapeutics AG MLTX | NCT06641076 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug | Arthritis, Psoriatic | active not recruiting | 960 |
| 2026-05-28 | P2 | Bausch & Lomb Incorporated BLCO | NCT07128628 A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease | Dry Eye Disease | completed | 443 |
| 2026-05-28 | P3 | Viridian Therapeutics, Inc. VRDN | NCT07155668 A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) | Thyroid Eye Disease | completed | 87 |
| 2026-05-28 | P2 | Bayer | NCT07582328 A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults | Nasal Congestion, Nasal Obstruction | completed | 120 |
| 2026-05-29 | P1/P2 | Amgen AMGN | NCT03600883 A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (Cod | KRAS p.G12C Mutant Advanced Solid Tumors | completed | 713 |
| 2026-05-29 | P2 | Incyte Corporation INCY | NCT04463771 Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Wh | Endometrial Cancer | completed | 206 |
| 2026-05-29 | P1/P2 | Kyverna Therapeutics KYTX | NCT05938725 KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis | Lupus Nephritis; Lupus Nephritis - World Health Organization (WHO) Class III; Lupus Nephritis - WHO | terminated | 6 |
| 2026-05-29 | P3 | Shandong Suncadia Medicine Co., Ltd. | NCT06589765 A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin | Type 2 Diabetes | completed | 810 |
| 2026-05-29 | P1/P2 | Be Biopharma | NCT06611436 BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B | Hemophilia B; Hemophilia B, Moderately Severe or Severe | terminated | 5 |
| 2026-05-29 | P2 | Carmot Therapeutics, Inc. | NCT06628362 A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus | Overweight or Obese; Type 2 Diabetes Mellitus (T2DM) | completed | 447 |
| 2026-05-29 | P2 | Evommune, Inc. EVMN | NCT06873516 Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) | Chronic Spontaneous Urticaria | completed | 182 |
| 2026-05-30 est. | P3 | Ganzhou Hemay Pharmaceutical Co., Ltd | NCT06145893 A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease | Behçet's Disease | recruiting | 162 |
| 2026-05-30 est. | P3 | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | NCT06633783 A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy® | Obesity | unknown | 370 |
| 2026-05-30 | P2 | Ono Pharmaceutical Co., Ltd. | NCT06752590 A Clinical Study of ONO-1110 in Patients With Fibromyalgia | Fibromyalgia | completed | 175 |
| 2026-05-30 est. | P3 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | NCT06885021 Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults | Overweight and Obesity | not yet recruiting | 780 |
| 2026-05-31 est. | P2 | Ascentage Pharma Group Inc. AAPG | NCT04496349 A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL | T-Prolymphocytic Leukemia; Non-Hodgkins Lymphoma | recruiting | 78 |
| 2026-05-31 est. | P2 | US Oncology Research | NCT04782687 Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma | Multiple Myeloma; Myeloma Multiple; Kahler Disease; Myeloma, Plasma Cell; Myeloma-Multiple; Myelomat | active not recruiting | 73 |
| 2026-05-31 est. | P2/P3 | Shanghai Pharmaceuticals Holding Co., Ltd | NCT05744687 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer | Locally Advanced or Metastatic Breast Cancer | recruiting | 374 |
| 2026-05-31 | P2 | Akeso | NCT05932212 AK104 for Recurrent or Metastatic Vulvar Cancer | Vulvar Cancer | terminated | 20 |
| 2026-05-31 | P3 | AstraZeneca AZN | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Ad | Gastric Cancer; Gastroesophageal Junction Cancer | active not recruiting | 594 |
| 2026-05-31 est. | P1/P2 | Miltenyi Biomedicine GmbH | NCT06347718 CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease | Systemic Lupus Erythematosus; Systemic Sclerosis; Dermatomyositis; Polymyositis | recruiting | 24 |
| 2026-05-31 est. | P3 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | NCT06394492 SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer | Ovarian Cancer | recruiting | 440 |
| 2026-05-31 est. | P2 | RemeGen Co., Ltd. | NCT06962865 A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or R | Non-Small Cell Lung Cancer | recruiting | 80 |
| 2026-05-31 est. | P1/P2 | Longbio Pharma | NCT07148557 A Study of Single Dose of LP-003 in Adolescent Subjects | Allergic Diseases | active not recruiting | 6 |
| 2026-05-31 est. | P1/P2 | Sinovac Biotech Co., Ltd SVA | NCT07400003 Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine | Herpes Zoster; mRNA Vaccine | recruiting | 519 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.